Video Library

This presentation provides a detailed explanation of what an autologous stem cell transplant is, who is a good candidate, the steps involved in undergoing an autologous transplant, short- and long-term side effects, and steps survivors can take to maximize their quality of life after transplant.

This presentation looks at how the foods we eat affect the gut and overall health. Dr. Damman explains why fiber, plant nutrients, healthy fats, and fermented foods are important, and discusses common nutrition questions for transplant patients, including probiotics, digestive symptoms, and how well certain foods are tolerated.

Dr. Tara Gregory reviews maintenance therapy for multiple myeloma after stem cell transplant and CAR-T-cell therapy, including treatment options, duration, side effect management, and the growing role of minimal residual disease (MRD) testing. She also discusses how CAR-T and bispecific antibodies are shaping the future of myeloma treatment.

This presentation explains how graft-versus-host disease (GVHD) can affect the gastrointestinal (GI) tract after an allogeneic transplant. It covers risk factors, common symptoms, treatment options, and ways patients can help manage symptoms and improve outcomes.

This presentation discusses the incidence and type of new cancers that may occur long-term after a bone marrow/stem cell transplant or CAR T-cell therapy, why they happen, how to detect symptoms, strategies to reduce the risk of new cancers, and long-term survivorship care plans.

This presentation explores how survivors can find meaning and purpose after cancer, transplant, CAR T, and chronic GVHD. Drs. El-Jawahri and Traeger discuss how reflection, personal strengths, values, and meaningful connections can help survivors make sense of their experiences and move forward.

Dr. Theresa Callard-Moore discusses how cancer treatment and transplant can affect sexual health, intimacy, and relationships. She covers common physical and emotional challenges and offers practical strategies for communication, rebuilding intimacy, managing discomfort, and getting support from the healthcare team.

Dr. Luke Mountjoy provides an overview of CAR T-cell therapy for lymphoma, including eligibility, how treatment works, expected benefits, side effects, and recovery. He also discusses infection risks, long-term considerations, and emerging CAR T approaches for lymphoma and other cancers.

This presentation reviews the latest advances in preventing and treating acute and chronic graft-versus-host disease (GVHD). Dr. Cutler discusses how post-transplant cyclophosphamide (PTCy) has changed GVHD prevention, new treatments for chronic GVHD, and research on combination therapies and early intervention. He also answers questions about clinical trials, treatment duration, and GVHD’s relationship to relapse.

This presentation reviews common lung complications after bone marrow transplant or CAR T-cell therapy, including BOS, organizing pneumonia, bronchiectasis, and restrictive lung disease. It also covers early diagnosis, pulmonary function testing, new imaging and treatment options, and ways to help preserve lung function and quality of life.

Graft-versus-host disease (GVHD) is a potential complication after a bone marrow/stem cell transplant using donor cells. This presentation explains what GVHD (GVHD) is, the difference between acute and chronic GVHD, risk factors for developing GVHD, how to monitor yourself to catch and report symptoms early, treatment options, and lifestyle changes that can improve GVHD symptoms.

Monitoring and maintaining oral health after transplant is an important part of recovery. This presentation describes typical issues with oral health after transplant, including graft-versus-host disease, and how to treat these conditions effectively.